RAD51C and ovarian serous adenocarcinoma: Another RAD51C truncating variant was a splice-site alteration, c.1026+5_1026+7delGTA, identified in a patient who developed endometrial carcinoma seven years after a diagnosis of ovarian serous adenocarcinoma.